▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2561 by analyst upside · 2026-09-27
NVST
Envista Holdings Corporation
Healthcare · Market Cap $4B · P/E 41.3x
ANALYST PRICE TARGET
+25.3%
implied upside to consensus target
Current Price $23.95
Consensus Target $30.0
Bull Target $35.0
Bear Target $23.0
Analysts Covering 13
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
5
Hold
6
Sell
0
52-Week Low $18.77
52-Week High $30.42
YTD Return +10.4%
FUNDAMENTALS
Market Cap $4B
P/E Ratio (TTM) 41.3x
Forward P/E 14.4x
EPS (TTM) $0.58
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $2.9B
Profit Margin 3.3%
52-WEEK RANGE
52-Week Low $18.77
52-Week High $30.42
Current Price $23.95
Bear Target $23.0
Bull Target $35.0
● Now $23.95 ● Target $30.0
TRADING DATA
Avg Volume 2.8M
YTD Return +10.4%
Analyst Count 13
Consensus Buy
Upside to Target +25.3%
Last Updated 2026-09-27

ANALYST SUMMARY

Envista Holdings Corporation (NVST) is currently trading at $23.95 with a Wall Street consensus price target of $30.0, implying potential upside of 25.3% over the next 12 months. 13 analysts currently cover NVST, with a consensus rating of Buy - 54% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $35.0, while the most cautious has a target of $23.0.

NVST operates in the Healthcare sector with a market capitalisation of $4B. The stock is up 10.4% year-to-date and is currently trading near the lower end of its 52-week range of $18.77 – $30.42.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for NVST, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Piper Sandler reit
Neutral → Neutral 2026-09-18 14% win rate (7 calls)
UBS - Reiterated
Neutral → Neutral 2026-09-18 33% win rate (6 calls)
Needham reit
Hold → Hold 2026-09-18 20% win rate (5 calls)
JP Morgan ↑ Upgrade
Neutral → Overweight 2026-09-03 43% win rate (7 calls)
Piper Sandler reit
Neutral → Neutral 2026-08-06 14% win rate (7 calls)
Piper Sandler - Reiterated
Neutral → Neutral 2026-07-29 14% win rate (7 calls)
BMO Capital ● Initiated
Market Perform 2026-07-09 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-06-11 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
47
out of 100
Coverage depth
20/30
Consensus clarity
20/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →